AmeriCann, Inc. (ACAN)

Market Cap	2.44K
Revenue (ttm)	799.18K -65.1%
Net Income	-2.38M
EPS	-0.10
Shares Out	24.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,225
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About AmeriCann

AmeriCann, Inc. designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States. The company’s flagship project is the Massachusetts Cannabis Center that is developed on a 52.6 -acre parcel of undeveloped land located in Freetown, Massachusetts. It also provides medical cannabis and adult-use cannabis. The company was formerly known as Nevada Health Scan, Inc. and changed its name to AmeriCann, Inc. in 2014. The company was incorporated in 2010 and is headquartered in Denver, Colorado.

• Industry: Real Estate Services
• Sector: Real Estate
• Founded: 2010
• Employees: 3
• Stock Exchange: OTCMKTS
• Ticker Symbol: ACAN

Financial Performance

In fiscal year 2024, AmeriCann's revenue was $1.27 million, a decrease of -50.05% compared to the previous year's $2.55 million. Losses were -$1.25 million, 1223.8% more than in 2023.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Sep 10, 2026

Data Sources Report a data error